← brief for 2026-09-03 · Slowing decline

GLP-1 Receptor Agonists, Lithium, and the Kidneys: A Tale of Two Signals.

Article No results yet Not peer reviewed

Key takeaways

This is a short commentary in a psychiatry journal about two drugs and the kidneys: GLP-1 medicines, the newer diabetes and weight drugs, and lithium, a mood medicine that can damage kidneys over years. No abstract was posted, so the argument it makes is not available here. It is an opinion piece, not a study, so there are no results yet.

Who did this work

Leung JG · Singh B

Source

Article · PubMed, the drug frontier · 2026 Sep 3
https://pubmed.ncbi.nlm.nih.gov/42690023/